e-Article
Lenalidomide, Adriamycin and Dexamethasone (RAD) Versus Bortezomib, Lenalidomide and Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma (MM) - Post-Induction Response and MRD Results By Flow Cytometry and NGS from a Phase 3 Randomized Controlled Clinical Trial (RCT)
Document Type
Journal
Author
Stuebig, Thomas; Langer, Christian; Engelhardt, Monika; Muegge, Lars-Olof; Bassermann, Florian; Schreder, Martin; Schaefer-Eckart, Kerstin; Blau, Igor Wolfgang; Wolleschak, Denise; Reichle, Albrecht; Metzler, Ivana; Metzner, Bernd; Rollig, Christoph; Hertenstein, Bernd; Duerk, Heinz; Biersack, Harald; Menzel, Helge; Dechow, Tobias; Schleicher, Jan; Gramatzki, Martin; Bruemmendorf, Tim H.; Fuhrmann, Stephan; Bittrich, Max; Appelt, Franziska; Mueller, Martina; Kroenke, Jan; Reusch, Julia; Schmidt, Christian; Brueggemann, Monika; Held, Swantje; Knop, Stefan; Einsele, Hermann
Source
Subject
Language
English
ISSN
15280020